A Peer-Reviewed Journal
February 2015 • Volume 4 • Number 1
PM O
BIOMARKERS • TARGETED THERAPIES • DIAGNOSTICS
Personalized Medicine in Oncology TM
HEMATOLOGIC MALIGNANCIES Novel Therapeutics Targeting CD19 and CD22 in Adult Acute Lymphoblastic Leukemia.................Page 14
LUNG CANCER CME Faculty Perspectives: Latest Treatment Advances for Individualized Care of NSCLC................... Page 22
COLORECTAL CANCER CME Faculty Perspectives: Latest Treatment Advances for Individualized Care of CRC..........................Page 34
WORLD CUTANEOUS MALIGNANCIES CONGRESS Case Presentation: International Focus on the Management of Acral Lentiginous Melanoma..................Page 42
PMO LIVE Case Report: Intense Maintenance in a Woman with High-Risk Multiple Myeloma.................... Page 48
THE LAST WORD To Regulate or Not Regulate LaboratoryDeveloped Tests, That Is the Question........... Page 58
GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™
The official publication of
GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™
WORLD CUTANEOUS MALIGNANCIES CONGRESS
© 2015 Green Hill Healthcare Communications, LLC An affiliation of The Lynx Group
WORLD CUTANEOUS
In partnership with
™